THE CRITICAL PATH INSTITUTE - BROAD AGENCY ANNOUNCEMENT (BAA) CONTRACT -- DEVELOPING NOVEL CLINICAL OUTCOME ASSESSMENTS FOR PEDIATRIC ASTHMA TO FACILITATE INNOVATIVE PATIENT-FOCUSED DRUG DEVELOPMENT AND AID REGULATORY DECISION MAKING
Key Details
Description
BROAD AGENCY ANNOUNCEMENT (BAA) CONTRACT -- DEVELOPING NOVEL CLINICAL OUTCOME ASSESSMENTS FOR PEDIATRIC ASTHMA TO FACILITATE INNOVATIVE PATIENT-FOCUSED DRUG DEVELOPMENT AND AID REGULATORY DECISION MAKING
Context & Analysis
On Oct 30, 2025, Department of Health and Human Services obligated $2,739,756.59 to THE CRITICAL PATH INSTITUTE for broad agency announcement (baa) contract -- developing novel clinical outcome assessments for pediatric asthma to facilitate innovative patient-focused drug development and aid regulatory decision mak…. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a cost no fee contract. Competition extent: full and open competition with 12 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in TUCSON, AZ. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.
Contractor Information
Similar Awards
NCI OPERATIONAL TASK ORDER, FY26-FY27
LEIDOS BIOMEDICAL RESEARCH INC
$327.1M
MD NET
LEIDOS BIOMEDICAL RESEARCH INC
$163.5M
ADVANCE UNIVERSAL INFLUENZA VACCINE - FLU MOSAIC VERSION 2 (FLUMOSV2)
LEIDOS BIOMEDICAL RESEARCH INC
$141.7M
AWARD OF THE BASE TO ST. JUDE FOR CEIRR CONTRACT 75N93021C00016. THIS CONTRACT WILL SUPPORT NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR).
ST JUDE CHILDREN'S RESEARCH HOSPITAL INC
$103.3M
DOMESTIC INDUSTRIAL BASE EXPANSION OF KEY CHEMICALS FOR ACRYLONITRILE BUTADIENE RUBBER (NBR)
ASCEND PERFORMANCE MATERIALS TEXAS INC
$87.7M
Stay Updated
Get notified about new opportunities matching your interests.